Researchers are combining immunotherapies with each other and with other treatments in hopes that a larger proportion of patients will have long-term benefits.

by Kate Yandell

Patient advocates meet amid an outcry about research funding cuts, participate in a meeting with FDA officials and visit Capitol Hill.

by Marci A. Landsmann

Cancer survivors tell their stories and researchers take a broad view.

by Kevin McLaughlin

For a patient with advanced cancer, how important is screening for other types of cancer?

by Ide Mills

Brain tumor survivor uses her experiences to help others.

by Jeannine Walston

Vice president cites immunotherapy, big data and team science as innovative ways to speed progress against cancer.

by Kevin McLaughlin